Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Pelthos Therapeutics Inc. (PTHS) had Income from Continuous Operations of $-43.32M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$16.80M |
|
$-43.32M |
|
$3.99M |
|
$12.81M |
|
$49.23M |
|
$-32.43M |
|
$-18.28M |
|
$-50.71M |
|
$-50.42M |
|
$-43.32M |
|
|
Income from Continuous Operations |
$-43.32M |
$-43.32M |
|
$-42.99M |
|
$-32.43M |
|
$-29.81M |
|
1.88M |
|
1.88M |
|
$-23.04 |
|
$-23.04 |
|
| Balance Sheet Financials | |
$53.41M |
|
$9.59M |
|
$76.99M |
|
$130.40M |
|
$25.99M |
|
$31.44M |
|
$65.52M |
|
$91.52M |
|
$38.88M |
|
$-25.27M |
|
$38.88M |
|
3.23M |
|
| Cash Flow Statement Financials | |
$-22.59M |
|
$-5.24M |
|
$45.34M |
|
$0.51M |
|
$18.02M |
|
$17.51M |
|
$5.46M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.05 |
|
-- |
|
-- |
|
0.45 |
|
0.81 |
|
76.25% |
|
-193.09% |
|
-193.09% |
|
-177.51% |
|
-301.91% |
|
-257.93% |
|
$-22.69M |
|
-- |
|
-- |
|
-- |
|
0.13 |
|
0.17 |
|
1.90 |
|
192.51 |
|
-111.41% |
|
171.42% |
|
-33.22% |
|
-61.60% |
|
$12.02 |
|
$-12.07 |
|
$-12.01 |
|